Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus

Enfuvirtide (ENF), the first approved fusion inhibitor (FI) for HIV, is a 36-aa peptide that acts by binding to the heptad repeat 1 (HR1) region of gp41 and preventing the interaction of the HR1 and HR2 domains, which is required for virus–cell fusion. Treatment-acquired resistance to ENF highlights...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Dwyer, John J., Wilson, Karen L., Davison, Donna K., Freel, Stephanie A., Seedorff, Jennifer E., Wring, Stephen A., Tvermoes, Nicolai A., Matthews, Thomas J., Greenberg, Michael L., Delmedico, Mary K.
Formato: Artigo
Idioma:Inglês
Publicado em: National Academy of Sciences 2007
Assuntos:
Biological Sciences
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1937542/
https://ncbi.nlm.nih.gov/pubmed/17640899
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0701478104
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados